1. Implications of the allosteric kinetics of cytochrome P450s;Atkins;Drug Discov. Today,2004
2. Boehringer Ingelheim in-house software package (property, developed by K.M. Hasselbach). Clark, T., Alex, A., Beck, B., Burkhardt, F., Chandrasekhar, J., Gedeck, P., Horn, A., Hutter, M.C., Martin, B., Rauhut, G., Sauer, W., Schindler, T., Steineke, T., 2005. University of Erlangen, Erlangen, Germany (This version is provided as part of Materials Studio 2.2.1 by Accelrys, Inc.).
3. Use of a microcomputer for the definition of multivariate confidence regions in medical diagnosis based on clinical laboratory profiles;Coomans;Comp. Biomed. Res.,1984
4. CORINA version 3.1, 2005. Molecular Networks GmbH, Erlangen, Germany.
5. Model based on GRID-derived descriptors for estimating CYP3A4 enzyme stability of potential drug candidates;Crivori;J. Comput. Aided Mol. Des.,2004